We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Henry Schein Inc (HSIC) COM STK NPV

Sell:$71.22 Buy:$71.24 Change: $3.46 (5.12%)
NASDAQ:2.77%
Market closed |  Prices as at close on 17 July 2024 | Switch to live prices |
Sell:$71.22
Buy:$71.24
Change: $3.46 (5.12%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 17 July 2024 | Switch to live prices |
Sell:$71.22
Buy:$71.24
Change: $3.46 (5.12%)
Market closed |  Prices as at close on 17 July 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Henry Schein, Inc. is a solutions company for health care professionals powered by a network of people and technology. The Company operates through two segments: health care distribution, and technology and value-added services. The health care distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, dental specialty products (including implant, orthodontic and endodontic products), diagnostic tests, infection-control products, personal protective equipment products and vitamins. The technology and value-added services segment provide software, technology and other value-added services to health care practitioners. It offers dental practice management solutions for dental and medical practitioners. It also develops solutions for the orthopedic treatment of lower extremities (foot and ankle) and upper extremities (primarily hand and wrist).

Contact details

Address:
135 Duryea Rd
MELVILLE
11747
United States
Telephone:
+1 (631) 8435500
Website:
https://www.henryschein.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
HSIC
ISIN:
US8064071025
Market cap:
$8.43 billion
Shares in issue:
128.05 million
Sector:
Health Care Distributors
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Stanley Bergman
    Chairman of the Board, Chief Executive Officer, Director
  • James Breslawski
    President, Vice Chairman of the Board, Director
  • Andrea Albertini
    President - International Distribution Group
  • Steve Boggan
    Co-Chief Executive Officer - Global Oral Reconstruction Group
  • Brad Connett
    Chief Executive Officer, North American Distribution Group
  • Tom Popeck
    Chief Executive Officer - Healthcare Specialties Group
  • Rene Willi
    Chief Executive Officer, Global Oral Reconstruction Group
  • Bianka Wilson
    Co-Chief Executive Officer - Global Oral Reconstruction Group
  • Michael Ettinger
    Chief Operating Officer, Executive Vice President
  • Lorelei Mcglynn
    Senior Vice President, Chief Human Resource Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.